WO2010043950A3 - Propafenone extended release composition - Google Patents

Propafenone extended release composition Download PDF

Info

Publication number
WO2010043950A3
WO2010043950A3 PCT/IB2009/007126 IB2009007126W WO2010043950A3 WO 2010043950 A3 WO2010043950 A3 WO 2010043950A3 IB 2009007126 W IB2009007126 W IB 2009007126W WO 2010043950 A3 WO2010043950 A3 WO 2010043950A3
Authority
WO
WIPO (PCT)
Prior art keywords
propafenone
extended release
release composition
release
rythmol
Prior art date
Application number
PCT/IB2009/007126
Other languages
French (fr)
Other versions
WO2010043950A2 (en
Inventor
Pavithra Anand
Balaji Sathurappan
Anand Sankaranarayanan
Durga Surya Prasad Chelamkuri
Original Assignee
Aizant Drug Research Solutions Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aizant Drug Research Solutions Private Limited filed Critical Aizant Drug Research Solutions Private Limited
Publication of WO2010043950A2 publication Critical patent/WO2010043950A2/en
Publication of WO2010043950A3 publication Critical patent/WO2010043950A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

An extended release propafenone mini tablets composition with in vitro release profile similar to that of Rythmol SR capsules without using any release retarding excipient wherein thee concentration of propafenone is less than or equal to 80%w/w.
PCT/IB2009/007126 2008-10-15 2009-10-14 Propafenone extended release composition WO2010043950A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2507/CHE/2008 2008-10-15
IN2507CH2008 2008-10-15

Publications (2)

Publication Number Publication Date
WO2010043950A2 WO2010043950A2 (en) 2010-04-22
WO2010043950A3 true WO2010043950A3 (en) 2010-12-02

Family

ID=41561456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/007126 WO2010043950A2 (en) 2008-10-15 2009-10-14 Propafenone extended release composition

Country Status (1)

Country Link
WO (1) WO2010043950A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
ES2903231T3 (en) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
WO2011154012A1 (en) * 2010-06-10 2011-12-15 Lifecycle Pharma A/S Mini-tablets comprising porous adsorbent material
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
CN103432094A (en) * 2013-09-11 2013-12-11 中国药科大学 Propafenone hydrochloride sustained-release preparation and preparation method thereof
CN107530168B (en) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 Device and method with reduced pacemaker ratio in heart valve replacement
CN105213349A (en) * 2015-10-10 2016-01-06 赛乐医药科技(上海)有限公司 A kind of propafenone hydrochloride sustained-release micro-pill capsules agent and its preparation method and application
WO2017195125A1 (en) 2016-05-13 2017-11-16 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CN105902984A (en) * 2016-05-29 2016-08-31 山东仁和堂药业有限公司 Propafenone hydrochloride tablets and preparation method thereof
CN109394722B (en) * 2018-12-26 2020-06-12 上海宣泰医药科技有限公司 Propafenone micro-tablet, multi-unit dosage form containing same, preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797287A (en) * 1984-06-19 1989-01-10 Basf Aktiengesellschaft Cylindrical microtablets
US5681588A (en) * 1993-04-03 1997-10-28 Knoll Aktiengesellschaft Delayed release microtablet of β-phenylpropiophenone derivatives
US20050271718A1 (en) * 2004-06-07 2005-12-08 Sherman Bernard C Sustained release propafenone hydrochloride capsules
BG108784A (en) * 2004-07-02 2006-02-28 "Софарма" Ад Medicamentous form of propaphenone and process for the preparation thereof
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469327A1 (en) 2004-06-07 2005-12-07 Bernard Charles Sherman Propafenone hydrochloride capsules containing microtablets
US20110091566A1 (en) 2007-09-25 2011-04-21 Nirmal Mulye Controlled release pharmaceutical compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797287A (en) * 1984-06-19 1989-01-10 Basf Aktiengesellschaft Cylindrical microtablets
US5681588A (en) * 1993-04-03 1997-10-28 Knoll Aktiengesellschaft Delayed release microtablet of β-phenylpropiophenone derivatives
US20050271718A1 (en) * 2004-06-07 2005-12-08 Sherman Bernard C Sustained release propafenone hydrochloride capsules
BG108784A (en) * 2004-07-02 2006-02-28 "Софарма" Ад Medicamentous form of propaphenone and process for the preparation thereof
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 20 September 2007 (2007-09-20), XP002604025, retrieved from STN Database accession no. 147:308278 *
S. MITCHELL ET AL.: "A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 97, no. 6, June 2008 (2008-06-01), pages 2277 - 2285, XP002604026 *

Also Published As

Publication number Publication date
WO2010043950A2 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2010043950A3 (en) Propafenone extended release composition
MY160399A (en) Compounds, compositions, and methods for preventing metastasis of cancer cells
WO2008128049A3 (en) Tetrahydrobiopterin compositions and methods of measuring
WO2008086462A3 (en) AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS
WO2009114773A3 (en) Modified release formulations of anti-irritability drugs
CL2012003048A1 (en) Compounds derived from n-phenyl-3- (1h-pyrazol-4-yl) quinoxalin-6-amine, fgfr tyrosine kinase inhibitors; Preparation process; pharmaceutical composition; and its use in the prevention or treatment of cancer.
HK1171245A1 (en) Alcoholic compositions having a lowered risk of acetaldehydemia
EP2272520A4 (en) Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients
MX2011012523A (en) Ketal esters of anhydropentitols and uses thereof.
WO2009055568A3 (en) Liposomal vancomycin formulations
WO2011025286A3 (en) Lipoteichoic acid-derived glycolipids, and compositions comprising same
EP2447253A4 (en) Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
ECSP088889A (en) NEW FORM OF ADMINISTRATION OF RACECADOTRIL
WO2006109344A3 (en) Composition to be used for the treatment of parodontal pathologies
WO2011134962A3 (en) Orally disintegrating tablet containing acarbose
ZA201200026B (en) Novel (6-oxo-1,6-dihydro-pyrimidin-2-yl)-amide derivatives,preparation thereof,and pharmaceutical use thereof as akt(pkb) phosphorylation inhibotors
IN2014MN01838A (en)
WO2010065586A3 (en) Preparation of capecitabine
AU2013257482A1 (en) Methods and compositions for administration of oxybutynin
EP2049117A4 (en) Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
WO2009120700A3 (en) Inhibition of dcps
IL213177A0 (en) Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
EP2051721A4 (en) Preparation and pharmaceutical use of euterpe oleracea (acai) extract compositions
EP2152232A4 (en) Methods and compositions for administration of oxybutynin
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09775274

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09775274

Country of ref document: EP

Kind code of ref document: A2